News

Engaging Investor Conferences with ORIC Pharmaceuticals

Engaging Investor Conferences with ORIC Pharmaceuticals

ORIC Pharmaceuticals Participates in Key Investor Conferences

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) is actively engaging with the investment community through a series of upcoming conferences. As a clinical-stage oncology company, ORIC focuses on innovative treatments that target mechanisms behind therapeutic resistance, aiming to enhance patient outcomes across various cancer types. In September, ORIC's management will be participating in several high-profile investor conferences that provide an excellent platform for showcasing their progress and insights.

Citi's 2025 Biopharma Back to School Summit

One of the highlights includes participation in Citi's 2025 Biopharma Back to School Summit. ORIC's management will conduct a fireside chat on a dedicated panel allowing for in-depth discussions regarding their groundbreaking strategies. The chat is scheduled to take place on September 3, 2025, at 4:00 p.m. Eastern Time. This engagement provides a unique opportunity for investors to gain direct insights into ORIC's mission and impact.

2025 Wells Fargo Healthcare Conference

Following the Citi Summit, ORIC's team will also attend the 2025 Wells Fargo Healthcare Conference, participating in another pivotal fireside chat. Set for September 4, 2025, at 2:15 p.m. Eastern Time, this conference serves as an influential gathering for healthcare investors and industry players. ORIC’s presence highlights its commitment to transparency and investor relations.

Cantor Global Healthcare Conference 2025

On September 5, 2025, ORIC will take part in the Cantor Global Healthcare Conference, where management will once again engage in a fireside chat session at 8:35 a.m. Eastern Time. These discussions are crucial for fostering relationships with investors and are expected to provide insights into ORIC’s advancements in addressing cancer treatment challenges.

Morgan Stanley and Baird Global Healthcare Conferences

Moreover, the team will hold a series of one-on-one meetings during the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025. This setting allows for personalized interactions, facilitating deeper dialogues on investment strategies and company initiatives. Additionally, ORIC will participate in the Baird 2025 Global Healthcare Conference on September 10, 2025, with another fireside chat scheduled for 1:25 p.m. Eastern Time.

Webcast Availability and Replays

Interested investors and individuals unable to attend can access webcasts of these fireside chats through the investor section of ORIC’s official website. Replays will be available for a period of 90 days post-event, ensuring that all interested parties have an opportunity to stay informed about ORIC's activities and innovations.

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company devoted to enhancing the lives of patients by addressing therapeutic resistance in cancer. Its flagship product candidates, including ORIC-944 and enozertinib (also known as ORIC-114), are grounded in innovative science aimed at overcoming significant barriers in cancer treatment. ORIC-944 targets the polycomb repressive complex through its allosteric inhibition, particularly focusing on prostate cancer. In parallel, enozertinib offers targeted solutions for various genetically-defined cancers by selectively engaging with critical mutations.

With offices located in South San Francisco and San Diego, California, ORIC actively continues its mission to advance cancer therapies. For more detailed information, check out the ORIC Pharma website and consider following them on social media platforms like X and LinkedIn.

Frequently Asked Questions

What is ORIC Pharmaceuticals known for?

ORIC Pharmaceuticals specializes in developing innovative cancer treatments aimed at overcoming mechanisms of therapeutic resistance.

When will ORIC participate in the Citi Summit?

ORIC will participate in the Citi's 2025 Biopharma Back to School Summit on September 3, 2025.

How can I access the webcasts of ORIC’s conferences?

Webcasts of the fireside chats will be available through the investor section of the ORIC website, with replays for 90 days after each event.

What are ORIC’s main product candidates?

ORIC’s main product candidates are ORIC-944, aimed at treating prostate cancer, and enozertinib (ORIC-114), which focuses on various genetically defined cancers.

Where is ORIC Pharmaceuticals located?

ORIC Pharmaceuticals has offices in South San Francisco and San Diego, California.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BarrelPick.com Launches for Bourbon Aficionados

Updated Category News Views 4

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Continue Reading
USPS Rolls Out Christmas Cookie Stamps Nationwide

Updated Category News Views 5

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Continue Reading
Qatar Foundation Spurs Sport-Driven Empowerment Moves

Updated Category News Views 4

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

Continue Reading
Why Liver Nurture Taps into Health Sector Trends

Updated Category News Views 5

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Continue Reading
Papa John's Faces Class Action Over Misleading Info

Updated Category News Views 5

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Continue Reading
Tragedy Highlights Need for E-bike Safety Overhaul

Updated Category News Views 5

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 9

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 4

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 7

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading

Top 5 Most Recently Viewed Articles

Quorum Information Technologies Reveals Upcoming Earnings Results

Updated Category News Views 316

Quorum Information Technologies Announces Earnings Release Date CALGARY, Alberta — Quorum Information Technologies Inc. (TSX-V: QIS), a prominent North American provider of SaaS software and essential services for automotive dealerships and original equipment manufacturers (OEMs), is set to share significant insights into its Q4 and fiscal year 2024 performance. The...

Continue Reading
Coherus Biosciences Faces Supply Challenges but Remains Optimistic

Updated Category News Views 81

Coherus Biosciences Faces Supply Challenges Baird has shown consistent support for Coherus Biosciences (NASDAQ: CHRS), keeping an Outperform rating and a price target of $8.00. This backing comes in light of the recent issues surrounding Udenyca, a vital biosimilar product. Supply disruptions have arisen from complications at their contract manufacturing organization...

Continue Reading
OrcaRouter Trims AI Model Costs with New Plans

Updated Category News Views 9

Talk about a game-changer spilling out from the AI trenches! OrcaRouter, long a stalwart in the AI infrastructure world, has rolled out a fresh set of monthly pricing plans—aimed squarely at making developers and enterprises a bit less squeezed by their AI budgets. The shiny new deal? Up to a neat 10% in bonus credits, doling out a monthly cushion to help keep those...

Continue Reading
TASE's Major Equity Indices Update: What to Expect Next

Updated Category News Views 176

A Historic Milestone for TASE The Tel Aviv Stock Exchange (TASE) is set to implement its largest-ever equity indices semi-annual update during the closing auction. This event signifies a crucial moment, driven by the remarkable growth of assets managed by funds that track TASE indices, which have reached a staggering NIS 82 billion. Such a striking increase in managed...

Continue Reading
Insights from Solutions30's Recent Annual General Meeting

Updated Category News Views 216

Solutions30 Annual General Meeting Outcomes Recent advancements in corporate governance and strategic initiatives were at the forefront during the Annual General Meeting of Solutions30 SE. Chaired by Gianbeppi Fortis, this engaging event took place in Luxembourg, highlighting the company's commitment to transparency and shareholder involvement. Key Resolutions Approved...

Continue Reading